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Abstract
Background: The prevalence of hypertension in Chinese Mainland has increased rapidly in the recent decades.
This study aimed to determine the prevalence of hypertension and sodium intake in an economically booming
area in China.
Methods: 9600 adults aged from 18 to 69 years old in Jiangsu Province of China were recruited using a complex,
multistage sampling method. Blood pressure was measured and a face-to-face interview was conducted among
all participants. 24 hours (24-h) urine sample was collected from each participant and then measured for sodium and
potassium. Hypertension was determined by blood pressure and use of anti-hypertension medications. All of the
analyses were weighted according to the population distribution in the province.
Results: Overall, the weighted means of systolic blood pressure (SBP) and diastolic blood pressure (DBP) were
128.8 mm Hg (95 % confidence interval, CI, 128.3–129.3) and 82.2 mm Hg (95 % CI, 81.4–83.1). The weighted
hypertension prevalence of Jiangsu residents was 33.0 % (95 % CI, 29.4–36.7 %). Among those with hypertension,
31.4 % (95 % CI, 24.6–38.1) were aware of their blood pressure condition. In total, 88.4 % (95 % CI, 83.5–93.3) of
those with known hypertension took anti-hypertension medications. Only 23.7 % (95 % CI, 13.3–34.2) of those
under anti-hypertension medications had their blood pressure controlled. The mean of 24-h urinary sodium
excretion was 188.2 mmol (standard deviation, SD, 69.5), representing that the mean intake of salt was 11.0 g
(SD, 4.1) through conversion.
Conclusion: Hypertension and excessive sodium intake in adults are prevalent in Jiangsu Province, China.
These observations suggest that a public health approach is necessary to prevent hypertension and manage
hypertensive patients.
Background
Hypertension is a major health problem worldwide. More
than 60 % of stroke cases and 40 % of coronary heart dis-
ease events were attributed to hypertension worldwide [1].
The prevalence of hypertension in general population was
approximately 25 %, and this number will increase mark-
edly by 60 % between 2000 and 2025 [2]. Pre-hypertension,
a physiological condition that blood pressure is not as high
enough as that defined as hypertension clinically, is also
revealed as one important cause of global mortality [3].
Reduced salt intake 50 mmol per day will decrease sys-
tolic blood pressure 4 mmHg and diastolic blood pressure
2.5 mmHg [4]. Excess dietary sodium is closely related to
the increase of blood pressure and clinically measured
hypertension. Furthermore, because excess sodium can
increase urinary calcium loss, it may also cause many
other adverse health outcomes such as ventricular fibrosis,
renal damage, gastric cancer, and osteoporosis [5].
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Jiangsu province lies in the eastern region of China with
a population of 73 million. In the province, cancer and car-
diovascular disease are the two major death-related causes
around the residents [6]. According to the monitoring data
from “The Chronic Disease And Its Risk Factors In Jiangsu
Province, 2010”, the prevalence of hypertension in resi-
dents aged 18 and older in Jiangsu province has reached
38.6 %. In addition, the average level of daily salt consump-
tion (11.2 g) was almost 2 times of the World Health
Organization guideline (6 g) [7].
Since 1970s, many countries launched campaigns to
reduce salt intake. Salt reduction is considered as a prior
measure to decrease the occurrence of cardiovascular
disease and the medical expense [8, 9]. The health bene-
fits of salt reduction action have been well documented.
Measures supported by policy, such as creating support-
ing environment, large-scale public education, adjusting
the formulation and implementation of “salty food label”,
can gradually reduce the sodium intake of population
[10]. These experiences show that the health promotion
strategies as comprehensive measures for salt intake re-
duction can prevent high blood pressure and related dis-
eases consequently.
The awareness, treatment and control of hypertension
in treated patients increased significantly from 1997 to
2009. However, these observed rates were all less than
30 % [11]; so the current measures for preventing and
treating hypertension still required to be enhanced. As a
result, Jiangsu provincial government started a salt reduc-
tion action on July 29, 2013, this project was led by the
provincial government and was aiming to reduce the risk
of hypertension and related diseases; and its baseline sur-
vey was carried out to understand the level of population
sodium intake and hypertension prevalence around the
whole province in 2013. These findings can improve a
targeting intervention to achieve the health goal of gov-
ernment: the awareness of salt knowledge reaching more
than 80 % and the provincial average level of salt intake
decreasing by more than 28 % at the end of 2015.
Methods
Sample size and sampling frame
The baseline survey of National Salt Reduction Action
was conducted between December 2013 and May 2014.
Respondents were restricted in persons who aged 18 to
69 years old and lived in the selected areas for 6 to
12 months before the investigation. The sample size
used for estimating hypertension prevalence of the pro-
vincial population was calculated as 9600, its calculation
formula was N¼ u2αp 1‐pð Þ
δ2
, and all parameters in this for-
mula were determined by the project plan; The required
sample size was 2400 for salt intake evaluation, the cal-
culation formula was N ¼ uασδ
 2
and parameters in this
formula also were determined by the project plan. Par-
ticipants without disability and mental disorders were
eligible to enter into the survey.
We used complex four-stage cluster sampling method
to recruit participants.
(1). Stage 1, 6 counties/districts were selected from 100
counties/districts following geographic distribution and
residence status (Binhu and Huishan district of Wuxi city
represent South Jiangsu, Jiangdu district and Baoying
county of Yangzhou city represent Middle Jiangsu, Xinyi
county in Xuzhou city and Ganyu county in Lianyungang
city represent North Jiangsu). The geographic location of
6 selected counties/districts is shown in Fig. 1.
(2). Stage 2, 4 towns (streets) were selected from each
county/district by using proportional probability sampling.
(3). Stage 3, we also used proportional probability sam-
pling to select 3 villages (neighborhood) randomly from
selected towns (streets) in Middle and South Jiangsu, and
5 villages (neighborhoods) from selected towns (street) in
North Jiangsu.
(4). Stage 4, we randomly selected 100 adults from the
local resident list in each selected village and neighborhood
community in Middle and South Jiangsu, and 120 adults in
North Jiangsu. A total of 9600 participants aged 18 to
69 years old were selected from 9600 households among 6
communities and villages. In each selected village, 25 (from
the middle and south) and 50 (from the north) of the
participants were selected for urine test. Overall, the urine
samples from 2400 adult participants were collected for
further laboratory tests. The details of sampling procedure
from stage 1 to stage 4 are shown in Fig. 2.
Measurements
This baseline survey includes questionnaire investigation,
physical measurement and laboratory tests. The question-
naire investigation and physical measurement were rec-
ommended for all selected participants. The amounts of
chemicals in the urine (a 24-h urine sample collection)
were subsequently determined by laboratory tests.
Questionnaire investigation
All of the families were invited to finish the family ques-
tionnaires containing family economic status and dietary
information. A personal questionnaire (details in additional
file 1) including individual social demography, hyperten-
sion related diseases conditions (ie. hypertension, diabetes,
stroke and coronary heart disease), related lifestyle (smok-
ing, alcohol use, diet and physical activity), related know-
ledge about salt intake and hypertension (health outcomes
of sodium intake and hypertension, perceptions of salt con-
sumption attitude and behaviors toward reducing salt in-
take), was answered by selected subjects.
Yongqing et al. BMC Public Health  (2016) 16:56 Page 2 of 8
Physical measurements
All respondents were invited to carry on the physical
measurements including blood pressure, height, weight,
waist circumference, hip circumference. These indexes
were measured by well-trained health staffs using na-
tional standard protocols [12]. For instance, electronic
sphygmomanometer (HEM-7071, Omron Corporation,
Kyoto, Japan) is required for the blood pressure meas-
urement, and the participants must keep in the sitting
position during the test. One valid test should repeat
every 5 min for 3 times by a single surrounding.
Body mass index (BMI) = weight (kg) / height 2 (m),
the definition of BMI categories is including: BMI less
than 18.5 is classified as lower weight, BMI ranging from
18.5 to 24.99 is classified as normal, BMI ranging from
25 to 28 is classified as overweight and BMI more than
28 is classified as obesity.
Laboratory tests
The 24-h urine specimens of respondents were collected
in standard urine collection containers. After the first
interview when the participants were given collection in-
structions, the beginning time and ending time of urine
collection for each participant were recorded and the
completeness of 24-h urine collection was evaluated [1].
Then, the containers of all respondents were taken back
and then transported on ice to the laboratory (ADICON
Clinical Laboratory Inc., Jinan, Shandong, China), where
the experiments were carried out according to the test-
ing methods. Urinary sodium, urinary potassium and
urinary creatinine were determined by the designated in-
spection agencies [13].
Urinary sodium and potassium were measured using ion
selecting electrode method in accordance with the exam-
ination protocols. Creatinine, as a quality control index,
was measured using the picric acid method. The com-
pleteness of 24-h urine collection was assessed based on
creatinine excretion. The urine sample with creatinine
reaching 1.91–18.27 mmol in man or 1.36–14.28 mmol in
Fig. 2 Participants in the baseline survey of the National Salt Reduction
Action in Jiangsu Province, China, in 2013
Fig. 1 Location of the sampled countries/districts in Jiangsu Province, China, Baseline Results From the National Salt Reduction Action in Jiangsu
Province, 2013. [13 prefecture-level cities in Jiangsu province are traditionally divided as north North Jiangsu (Xuzhou, Lianyungang, Suqian, Yancheng
and Huaian), middle Middle Jiangsu (Yangzhou, Taizhou and Nantong) and south South Jiangsu (Nanjing, Zhenjiang, Changzhou, Wuxi and Suzhou)
with geographic distribution and economic status]
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woman was considered an acceptable collection [14].
Based on assumption that all ingested sodium was in the
form of sodium chloride, quantity of 24-h urinary sodium
excretion was used estimating daily salt intake [1].
Ethical approval of this study was obtained from the
“Ethical Committee of Chinese National Center of Disease
Control and Prevention”. And all respondents in this in-
vestigation had received and signed a papery informed
consent form from Ethical Committee of Chinese National
Center of Disease Control and Prevention.
Hypertension definition
The participant was classified as hypertension if sys-
tolic blood pressure (SBP) was greater than or equal to
140 mm Hg, or diastolic blood pressure (DBP) was greater
than or equal to 90 mm Hg, or he/she underwent anti-
hypertension medication in the previous 2 weeks. Among
the hypertensive participants, self-report of any previous
clinical diagnosis of hypertension was defined as aware-
ness of hypertension. Self- reported anti-hypertension
medication usage was defined as treatment of hyperten-
sion among the participants with hypertension awareness.
Finally, mean SBP of less than 140 mm Hg or DBP of less
than 90 mm Hg was defined as control of hypertension
among those treated participants [15].
Data analysis
Sample weights were determined by the design weight
and post-stratification weight. The design weight was
calculated by combination of cluster design, strata and
individual. And the calculation of post-stratification
weight depended on general population distribution of
Jiangsu Province in 2014 [16].
All of the data in the survey were collected and inputted
by using EpiData Entry 3.1 (The EpiData Association,
Odense, Denmark). Statistical analysis were performed
with SPSS (version 19.0, SPSS Inc., Chicago, Illinois, USA)
and SAS software 9.3 (SAS Inc., Cary, North Carolina,
USA). When P value was less than 0.05 (Two sided P <
0.05), the difference was considered statistically significant.
Results were expressed as median and 95 % confi-
dence interval (95 % CI) or mean ± SD. Variances of
mean and proportion were estimated and 95 % confi-
dence intervals (CIs) were calculated. Rao-Scott χ2 test
was used for comparisons of rates between different
characteristics such as household registers, sexes and
age groups, while Student’s t-test and analysis of vari-




Of the 9600 individuals invited to this study, 9533 individ-
uals (4650 men, 4883 women) responded and participated
in our survey. The response rate is 99.3 %. A total of 2202
individuals completed the 24-h urine collection, yielding a
response rate of 91.8 %.
The mean age of the samples was 41.55 (SD, 13.797)
years old. Of the participants, 2620 (27.9 %) participants
were current smokers. The prevalence of overweight and
obesity was 36.6 and 14.6 %, respectively. Based on the
body mass index (BMI), 264 (3.1 %) participants were
classified as low weight (BMI < 18.5), 4344 (45.7 %) were
normal (18.5≦BMI < 25), 3496 (36.6 %) were overweight
(25≦BMI < 28), and 1410 (14.6 %) were obese (BMI≧28).
All details of respondents’ characteristics are shown in
Table 1.
Blood pressure and awareness, treatment and control of
hypertension
Overall, the means of SBP and DBP were 128.8 mmHg (95
% CI, 128.3–129.3) and 82.2 (95 % CI, 81.4–83.1) mmHg,
respectively. Men had higher SBP (132.2 mmHg (95 % CI,
131.1–133.3) VS 125.4 (95 % CI, 124.2–126.7) mmHg) and
DBP (84.3 mmHg (95 % CI, 82.9–85.7) VS 80.1 mmHg (95
% CI, 79.4–80.9)) than women. Urban residents had lower
SBP (124.6 mmHg (95%CI, 122.2–127.0) VS 131.6 mmHg
(95 % CI, 131.1–132.1)) and DBP (81.3 mmHg (95 % CI,
79.5–83.1) VS 82.8 mmHg (95 % CI, 82.0–83.7)) than
rural residents.
The hypertension prevalence of Jiangsu residents was
33.0 % (95 % CI, 29.4–36.7 %). Among those with hyper-
tension, 31.4 % (95 % CI, 24.6–38.1 %) were aware of their
blood pressure condition, and 88.4 % of residents with
awareness had self-report of taking anti-hypertension
medications now; Finally, 23.7 % (95 % CI, 13.3–34.2 %) of
residents undergoing anti-hypertension medications had
their blood pressure controlled.
The prevalence of hypertension was higher in men than
in women (39.0 % (95 % CI, 31.9–46.1 %) VS 27.0 % (95 %
CI, 26.1–28.0 %)). There was a significant urban/rural dif-
ference in the prevalence of hypertension: 36.2 % (95 % CI,
30.7–41.7 %) for rural residents and 28.2 % (95 % CI,
21.4–35.1 %) for urban residents.
Among those with hypertension, there were significant
gender and urban/rural differences in awareness and treat-
ment of hypertension (P < 0.05). Men had lower awareness
and treatment of hypertension than women, while the
urban residents had higher awareness of hypertension
than the rural residents (Table 2). The prevalence of
awareness and treatment of hypertension was 28.6 %
(95 % CI, 19.8–37.5 %) and 86.7 % (95 % CI, 82.2–91.1 %)
in men as compared with 35.3 % (95 % CI, 31.0–39.6 %)
and 90.4 % (95 % CI, 84.3–96.5 %) in women.
Among the residents who underwent anti-hypertension
medications presently, difference in the control of hyper-
tension was not observed between the male and the fe-
male (P = 0.24), and also not found between the rural and
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the urban areas (P = 0.17). There were no significant gen-
der and urban/rural differences in the control of hyperten-
sion. All details of respondents’ blood pressure and
awareness, treatment and control of hypertension are
shown in Table 2.
Urinary sodium and potassium
As shown in Table 3, the mean 24-h urinary sodium and
potassium excretion were 188.2 mmol (SD, 69.45) and
28.0 mmol (SD, 9.50), respectively. The mean of salt in-
take converted from urinary sodium was 11.0 g (SD,
4.06). Differences were found in 24-h urinary sodium
excretion between different populations. For instance,
rural residents excreted more sodium than urban resi-
dents (P < 0.01); the males excreted more sodium than
the females (P < 0.01). Among the samples, only 8.6 %
(95 % CI, 7.3–9.9 %) had urinary sodium <102.46 mmol
(equivalent to salt intake of 6 g/d). All details of respon-
dents’ urinary sodium and potassium are shown in
Table 3.
Discussion
Our study has found that the hypertension prevalence of
residents in Jiangsu province was 33.0 % in 2014, as a re-
sult, one hypertensive patient was potentially detected
from three residents aged from 18 to 69 years old in
Jiangsu province. In former studies, the prevalence of
hypertension in Chinese population increased signifi-
cantly from 1991 to 2009 [11], while another surveil-
lance data from Chronic Disease and Its Risk factors
Surveillance in China also confirmed this characteristic
in Jiangsu province that the standardized rates of hyper-
tension prevalence in residents aged more than 15 years
old in 2002, 2007 and 2010 was 25.1, 33.8 and 38.6 %,
Table 2 Means of SBP, DBP and prevalence, awareness, treatment and control of hypertension in Jiangsu Province
Measure Total Sex Urban/Rural
Male Female P Urban Rural P
Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI Mean 95 % CI
SBP 128.8 128.3–129.3 132.2 131.1–133.3 125.4 124.2–126.7 P < 0.05 124.6 122.2–127.0 131.6 131.1–132.1 P < 0.05
DBP 82.2 81.4–83.1 84.3 82.9–85.7 80.1 79.4–80.9 P < 0.05 81.3 79.5–83.1 82.8 82.0–83.7 P < 0.05
Prevalence of hypertension 33.0 29.4–36.7 39.0 31.9–46.1 27.0 26.1–28.0 P < 0.01 28.2 21.4–35.1 36.2 30.7–41.7 P = 0.03
Awareness of hypertension 31.4 24.6–38.1 28.6 19.8–37.5 35.3 31.0–39.6 P < 0.01 41.7 28.1–55.3 26.0 16.7–35.3 P = 0.02
Treatment of hypertension 88.4 83.5–93.3 86.7 82.2–91.1 90.4 84.3–96.5 P=0.03 90.9 84.3–97.5 86.3 79.4–93.1 P = 0.19
Control of hypertension 23.7 13.3–34.2 24.7 14.7–34.8 22.6 11.2–34.0 P=0.24 29.3 20.3–38.3 18.8 3.0–34.6 P = 0.17
Table 1 Characteristics of study participants in different sex of Jiangsu population
Characteristic Total Urban Rural Male Female
N % 95 % CI N % 95 % CI N % 95 % CI N % 95 % CI N % 95 % CI
Age (years) 18–34 3281 35.7 30.1–41.4 1206 42.2 35.7–48.7 2075 31.4 23.0–39.8 1592 35.7 29.3–42.0 1689 35.8 30.7–40.8
35–49 3394 35.2 32.0–38.4 1312 34 30.6–37.6 2082 36 31.3–40.7 1632 34.9 30.8–39.0 1762 35.5 33.1–37.9
50–69 2858 29.1 25.6–32.6 1060 23.8 18.9–28.9 1798 32.6 27.7–37.5 1426 29.4 25.8–33.1 1432 28.7 25.3–32.1
Ethnicity Han 9508 99.7 99.6–99.9 3570 99.8 99.6–100 5938 99.7 99.6–99.8 4646 99.9 99.8–100 4862 99.6 99.4–99.8
Other 25 0.3 0.1–0.4 8 0.2 0.0–0.4 17 0.3 0.2–0.4 4 0.1 0–0.2 21 0.4 0.2–0.6
Education (years) 0 1434 14.7 12.5–17.0 118 3.1 0–7.9 1316 22.5 20.1–24.8 374 7.8 5.7–9.9 1060 21.7 19.7–23.7
1–5 1618 16 14.2–18.0 454 11.2 5.3–17.0 1164 19.4 18.1–20.7 695 14.4 12.8–16.1 923 17.7 15.2–20.3
6–8 3625 36.8 33.4–40.3 1303 35 27.8–42.1 2322 38.1 34.7–41.5 1916 39.9 34.9–44.9 1709 33.8 30.8–36.6
9–11 1716 18.7 16.6–20.9 827 23.9 20.4–27.5 889 15.3 12.7–17.9 1034 22.8 20.5–25.2 682 14.6 12.6–16.7
>12 1134 13.6 9.1–18.1 876 26.8 14.8–38.9 258 4.8 0.3–9.3 527 15 10.0–20.0 507 12.2 7.6–16.8
Smoking status Current 2620 27.9 25.3–30.5 958 26.4 20.0–32.7 1662 28.9 27.4–30.4 2540 53.9 49.2–58.6 80 1.8 0.7–2.9
Former 251 2.6 1.6–3.5 85 1.9 0–3.9 166 3 2.5–3.6 242 5 3.1–6.8 9 0.2 0–0.3
Never 6653 69.5 66.6–72.4 2535 71.7 65.1–78.4 418 68.1 66.0–70.1 1868 41.1 36.0–46.3 4785 98 97.1–99.0
BMI Low weight 264 3.1 2.3–3.8 148 4.6 2.5–6.7 116 2 1.3–2.8 103 2.4 1.6–3.2 161 3.7 2.8–4.7
Normal 4344 45.7 41.3–50.1 1751 49.2 41.4–57.1 2593 43.4 37.2–49.5 2000 42.3 36.1–48.8 2344 49 44.2–53.8
Overweight 3496 36.6 33.2–40.1 1244 34.1 27.8–40.4 2252 38.3 33.5–43.1 1825 39.5 34.9–44.2 1671 33.7 30.7–36.7
Obese 1410 14.6 12.2–17.0 432 12 8.0–16.0 978 16.3 12.9–19.7 715 15.6 13.3–17.9 695 13.6 9.3–17.8
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respectively [17]. In brief, these surveillance data all indi-
cate a tendency of rising hypertension burden in China
and Jiangsu province in recent years; Although compar-
ing these hypertension prevalence directly is unsuitable,
such level of hypertension is still too high to be paid
enough attention by the government. It is also shown in
former study in Chinese population that the prevalence
was higher in successive age groups [18], so ageing of
population may increase this rising tendency. In conclu-
sion, our results suggest that hypertension prevalence
rate is still in high level in 2014, which remains a provin-
cial public health problem.
It was also found that hypertension prevalence of the
male was higher than that of the female. Indeed, we found
that the current smoking rate was significant higher in
men than in women, and there were more people over-
weight and obese in the male. Because smoking and
BMI status are found as risk factors of hypertension
[19], tobacco reduction and body weight control must
be firstly introduced in future policy formulated by the
local government.
Former studies at the national level have discovered
that hypertension among rural population increased fas-
ter than urban population from 2002 to 2010 [20]; In
2014, the hypertension prevalence in urban residents
was lower than in rural residents in Jiangsu province;
These all suggest that hypertension is more prevalent in
rural areas. Economic improvement may be an import-
ant reason of this phenomenon, economic improvement
in rural areas of China have deeply changed the living
standard and economic capacity of the residents there,
and risk factors grow dramatically. For instance, obesity
and overweight of rural population were increasing fas-
ter than those of urban residents by improvement of
economic capacity [21].
The control of blood pressure to normal level can re-
duce the risk of cardiovascular diseases and prevent these
vascular events [22]. Our study have found that among
those aware of their hypertension condition, blood pres-
sure control rate of the whole Jiangsu residents was still
low, only 23.7 % which was even lower than that of neigh-
boring Shangdong province (43.2 %), and much lower
than that found in the United States [23, 24]. The compar-
isons on hypertension awareness and treatment of popula-
tion in different areas and with different sexual
distinctions also derive an imbalance, which mainly in-
clude the rural and the male have much lower awareness
and treatment level.
The control of hypertension is closely related to the
factors such as, awareness of blood pressure level, the
technical levels of medical staffs, patients’ medication
adherence and life styles [9]. Firstly, the hypertension
awareness of those residents who were classified as hyper-
tension was rather low, so the undiscovered hypertensive
patients accounted for a significant proportion, which indi-
cate that the examination of hypertension is not still fully
covered by current health service. Secondary, current self-
reported anti-hypertension medication rate (88.4 %) was
optimistic and acceptable, reflecting that high accessibility
of treatment services have developed in Jiangsu province.
At last, the hypertension control rate (23.7 %) was still low
among those who underwent anti-hypertension medica-
tions, probably, treatment methods and patients’ medica-
tion adherence co-influenced the effect of therapy. In brief,
both the blood pressure screening and the effect of medi-
cation should be emphasized to increase hypertension
control in policies of the future National Salt Reduction
Action.
In our survey, we found that the mean of salt consump-
tion converted from urinary sodium in 24-h urine collec-
tion was 11.0 g, and only 8.6 % of all residents’ salt intake
was below the recommended level (6 g) according to the
dietary intake guidelines of Chinese residents [7]. The
attention of salt reduction for hypertension control has
been increasing throughout the world [25], and the World
Health Organization (WHO) has recommended that
adults consume no more than 5 g of salt per day (equiva-
lent to 2000 mg of sodium) in 2003 [26]. In addition, total
salt intake in our study would be estimated to 12.2 g when
considering that approximately 10 % of sodium was
Table 3 Urinary sodium and potassium excretion in different populations
24 h Urinary
measure
N Sodium (Mmol/24 h) Potassium (Mmol/24 h) 24 h Na/K Converted Salt(g)
Mean ± SD P Mean ± SD P Mean ± SD P Mean ± SD P
Sex Male 1069 196.36 ± 72.29 P < 0.01 28.37 ± 10.07 P = 0.07 7.14 ± 2.00 P < 0.01 11.49 ± 4.23 P < 0.01
Female 1133 180.47 ± 65.77 27.64 ± 8.92 6.69 ± 1.96 10.56 ± 3.85
Residence Urban 823 205.23 ± 71.35 P < 0.01 29.97 ± 10.18 P < 0.01 7.09 ± 2.07 P < 0.01 12.01 ± 4.17 P < 0.01
Rural 1379 178.02 ± 66.26 26.81 ± 8.86 6.80 ± 6.80 10.41 ± 3.88
Age 18–34 625 189.55 ± 69.94 P = 0.19 26.47 ± 8.76 P < 0.01 7.30 ± 1.98 P < 0.01 11.09 ± 4.09 P = 0.19
35–49 731 190.91 ± 71.66 28.34 ± 9.96 6.92 ± 1.93 11.17 ± 4.19
50–69 846 184.82 ± 67.05 28.81 ± 9.49 6.59 ± 2.00 10.81 ± 3.92
Total 2202 188.19 ± 69.45 27.99 ± 9.50 6.91 ± 1.99 11.00 ± 4.06
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excreted in sweat and feces, so excess sodium intake is
prevalent in Jiangsu province.
To develop future intervention for control of hyperten-
sion, we need to combine our findings and those in other
studies to adopt one advance and comprehensive method.
Interestingly, the association between residents’ know-
ledge and attitudes of salt and their behaviors of actual salt
consumption is not clear, which suggests that interven-
tions focused only on knowledge, attitudes and behaviors
may be of limited efficacy [27]. As being a trad-
itional measure, a single intervention by a health care pro-
vider, such as the propaganda of high blood pressure
knowledge, can positively impact lifestyle choices, but the
extent of this impact was relatively small [28]. So a com-
bination with salt reduction action should draw the atten-
tion of governments, and compulsory measure should be
put to use. In fact, despite modest effect of dietary sodium
restriction cultivated by government, the diet without
addition of salt significantly decreased systolic and dia-
stolic BP, and it should be advised for every hypertensive
patient [29].
In other country, a gradual sodium reduction (10–15 %
over multiple years) strategy leading to the adjustment of
salt taste of the population was found valid and suitable
[30]. In England, packaged food producers were the main
salt using departments [31]. Differently, the major sources
of sodium intake are condiments added during house
cooking in China [32], so health education and health pro-
motion should widely affect cooking habits of many house-
wives, such as the generation of quantitative salt spoon.
For the people unwilling or fail to taste ease, low so-
dium salt as an alternative is undoubtedly more attract-
ive. A kind of salt with reduced sodium and increased
potassium is now being used in northern Chinese prov-
inces [33]. Salt substitute might be a perfect strategy to
reduce sodium consumption and control hypertension.
The interdependency of Na and K in the pathogenesis of
hypertension indicates that Na restriction and increased
K intake are important strategies for the primary preven-
tion and treatment of hypertension and its cardiovascu-
lar consequences [32].
It was the first time to conduct large scale investigation
of 24-h urinary samples in Jiangsu province. Our team has
established an impeccable quality-control system for all
links, which is valuable for future population studies. How-
ever, our study has also faced several limitations. Firstly,
large representative sample was difficult to be involved in
our completed survey. Non-responding participants were
not substituted by randomly selected individuals. Only 6
counties were selected around the whole province in the
first sampling stage, which also made the uncertainty big-
ger in estimation of 95 % CI. Secondly, the stability of elec-
tronic sphygmomanometer is not as reliable as mercurial
sphygmomanometer, and blood pressure measurements
on a single occasion (although 3 measurements were taken
on that 1 occasion) could not substitute a clinical diagnosis
of hypertension. These all increased the bias in blood pres-
sure level measurement. Lastly, creatinine was used to
substitute PABA as the biomarker for judging the com-
pleteness of 24-h urinary samples, which might have re-
sulted in the inclusion of noneligible samples or the
exclusion of eligible samples.
Conclusion
The overall prevalence of hypertension increased signifi-
cantly in Jiangsu province between 2002 and 2010, we
found it was still in the high level in 2014, and the overall
awareness and control of hypertension were still in un-
acceptably low level. While the sodium intake was ser-
iously above the recommended level. These observations
suggest that a public health approach guided by govern-
ment, which including sodium intake reduction and other
strategies, is urgently needed to make substantial gains in
the prevention and management of hypertension-related
morbidity and mortality [34].
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